PRESS RELEASE published on 07/21/2023 at 08:55, 2 years 11 months ago 029 Group SE: Portfolio company Hotelbird introduces a new fully automated kiosk solution
PRESS RELEASE published on 06/29/2023 at 11:39, 2 years 11 months ago EQS-Adhoc: 029 Group SE: Change in the Administrative Board
PRESS RELEASE published on 06/29/2023 at 10:35, 2 years 11 months ago 029 Group SE: Changes in the Administrative Board
PRESS RELEASE published on 04/25/2023 at 22:48, 3 years 2 months ago 029 Group SE: Publication of Annual Report 2022
PRESS RELEASE published on 04/05/2023 at 10:12, 3 years 2 months ago 029 Group SE: portfolio company TRIP named fastest growing drinks brand in the UK
PRESS RELEASE published on 03/08/2023 at 10:04, 3 years 3 months ago 029 Group SE: AlsterResearch initiates coverage of 029 Group with ‘Hold’ recommendation
PRESS RELEASE published on 02/07/2023 at 10:21, 3 years 4 months ago 029 Group SE: portfolio company TRIP reports an 800% increase in UK sales throughout January across large retailers
Published on 06/26/2026 at 14:05, 1 hour 25 minutes ago SouthGobi Announces Voting Results of Annual General Meeting of Shareholders
Published on 06/26/2026 at 14:00, 1 hour 30 minutes ago Dateline Chairman Invests $1.95 million through Options Exercise
Published on 06/26/2026 at 13:00, 2 hours 30 minutes ago Aclara Secures Tax Exemption Approval of Over US$20 Million For Its U.S. Heavy Rare Earth Separation Facility in Louisiana
Published on 06/26/2026 at 12:45, 2 hours 45 minutes ago Northern Dynasty Reports Oral Arguments Held
Published on 06/26/2026 at 15:17, 12 minutes ago Form 8.3 - The Vanguard Group, Inc.: Intertek Group plc
Published on 06/26/2026 at 15:17, 12 minutes ago Form 8.3 - The Vanguard Group, Inc.: International Personal Finance plc
Published on 06/26/2026 at 15:16, 13 minutes ago Form 8.3 - The Vanguard Group, Inc.: Gamma Communications plc
Published on 06/26/2026 at 07:00, 8 hours 30 minutes ago Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/26/2026 at 07:00, 8 hours 30 minutes ago Améliorer la santé des femmes grâce au diagnostic rapide : bioMérieux dépose auprès de la FDA une demande combinée d’autorisation 510(k) et de dérogation CLIA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel
